[1]
|
Rösch, J., Hanafee, W., Snow, H., et al. (1971) Transjugular Intrahepatic Portacaval Shunt. An Experimental Work. American Journal of Surgery, 121, 588-592. https://doi.org/10.1016/0002-9610(71)90147-4
|
[2]
|
Richter, G.M., Palmaz, J.C., Nöldge, G., et al. (1989) The Transjugular Intrahepatic Portosystemic Stent-Shunt. A New Nonsurgical Percutaneous Method. Der Radiologe, 29, 406-411.
|
[3]
|
Kibble, H. and Shawcross, D.L. (2024) The Assessment and Management of Cirrhotic Patients with Encephalopathy. United European Gastroenterology Journal, 12, 187-193. https://doi.org/10.1002/ueg2.12530
|
[4]
|
Vilstrup, H., Amodio, P., Bajaj, J., et al. (2014) Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology (Baltimore, Md), 60, 715-735. https://doi.org/10.1002/hep.27210
|
[5]
|
Riggio, O., Nardelli, S., Moscucci, F., et al. (2012) Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt. Clinics in Liver Disease, 16, 133-146. https://doi.org/10.1016/j.cld.2011.12.008
|
[6]
|
Zuo, L., Lv, Y., Wang, Q., et al. (2019) Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation. Journal of Vascular and Interventional Radiology: JVIR, 30, 148-153.E2. https://doi.org/10.1016/j.jvir.2018.08.023
|
[7]
|
Ortiz, M., Jacas, C. and Córdoba, J. (2005) Minimal Hepatic Encephalopathy: Diagnosis, Clinical Significance and Recommendations. Journal of Hepatology, 42, S45-S53. https://doi.org/10.1016/j.jhep.2004.11.028
|
[8]
|
Weissenborn, K. (2015) Diagnosis of Minimal Hepatic Encephalopathy. Journal of Clinical and Experimental Hepatology, 5, S54-S59. https://doi.org/10.1016/j.jceh.2014.06.005
|
[9]
|
Karanfilian, B.V., Park, T., Senatore, F., et al. (2020) Minimal Hepatic Encephalopathy. Clinics in Liver Disease, 24, 209-218. https://doi.org/10.1016/j.cld.2020.01.012
|
[10]
|
Sharma, P., Sharma, B.C., Puri, V., et al. (2007) Critical Flicker Frequency: Diagnostic Tool for Minimal Hepatic Encephalopathy. Journal of Hepatology, 47, 67-73. https://doi.org/10.1016/j.jhep.2007.02.022
|
[11]
|
Torlot, F.J., Mcphail, M.J. and Taylor-Robinson, S.D. (2013) Meta-Analysis: The Diagnostic Accuracy of Critical Flicker Frequency in Minimal Hepatic Encephalopathy. Alimentary Pharmacology & Therapeutics, 37, 527-536. https://doi.org/10.1111/apt.12199
|
[12]
|
Berlioux, P., Robic, M.A., Poirson, H., et al. (2014) Pre-Transjugular Intrahepatic Portosystemic Shunts (TIPS) Prediction of Post-TIPS Overt Hepatic Encephalopathy: The Critical Flicker Frequency Is More Accurate than Psychometric Tests. Hepatology (Baltimore, Md), 59, 622-629. https://doi.org/10.1002/hep.26684
|
[13]
|
Hadjihambi, A., Harrison, I.F., Costas-Rodríguez, M., et al. (2019) Impaired Brain Glymphatic Flow in Experimental Hepatic Encephalopathy. Journal of Hepatology, 70, 40-49. https://doi.org/10.1016/j.jhep.2018.08.021
|
[14]
|
Bjerring, P.N., Gluud, L.L. and Larsen, F.S. (2018) Cerebral Blood Flow and Metabolism in Hepatic Encephalopathy—A Meta-Analysis. Journal of Clinical and Experimental Hepatology, 8, 286-293. https://doi.org/10.1016/j.jceh.2018.06.002
|
[15]
|
Görg, B., Karababa, A. and Häussinger, D. (2018) Hepatic Encephalopathy and Astrocyte Senescence. Journal of Clinical and Experimental Hepatology, 8, 294-300. https://doi.org/10.1016/j.jceh.2018.05.003
|
[16]
|
Weiss, N., Barbier, S., Hilaire, P., Colsch, B., et al. (2016) Cerebrospinal Fluid Metabolomics Highlights Dysregulation of Energy Metabolism in Overt Hepatic Encephalopathy. Journal of Hepatology, 65, 1120-1130. https://doi.org/10.1016/j.jhep.2016.07.046
|
[17]
|
Dam, G., Keiding, S., Munk, O.L., et al. (2013) Hepatic Encephalopathy Is Associated with Decreased Cerebral Oxygen Metabolism and Blood Flow, Not Increased Ammonia Uptake. Hepatology (Baltimore, Md), 57, 258-265. https://doi.org/10.1002/hep.25995
|
[18]
|
Lu, K., Zimmermann, M., Görg, B., et al. (2019) Hepatic Encephalopathy Is Linked to Alterations of Autophagic Flux in Astrocytes. EBioMedicine, 48, 539-553. https://doi.org/10.1016/j.ebiom.2019.09.058
|
[19]
|
Coronado, W.M., Ju, C., Bullen, J., et al. (2020) Predictors of Occurrence and Risk of Hepatic Encephalopathy after TIPS Creation: A 15-Year Experience. Cardiovascular and Interventional Radiology, 43, 1156-1164. https://doi.org/10.1007/s00270-020-02512-7
|
[20]
|
Bai, M., Qi, X., Yang, Z., et al. (2011) Predictors of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients: A Systematic Review. Journal of Gastroenterology and Hepatology, 26, 943-951. https://doi.org/10.1111/j.1440-1746.2011.06663.x
|
[21]
|
Casadaban, L.C., Parvinian, A., Minocha, J., et al. (2015) Clearing the Confusion over Hepatic Encephalopathy after TIPS Creation: Incidence, Prognostic Factors, and Clinical Outcomes. Digestive Diseases and Sciences, 60, 1059-66. https://doi.org/10.1007/s10620-014-3391-0
|
[22]
|
Nardelli, S., Lattanzi, B., Torrisi, S., et al. (2017) Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Placement. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association, 15, 934-936. https://doi.org/10.1016/j.cgh.2016.10.028
|
[23]
|
Luo, S.H., Zhou, M.M., Cai, M.J., et al. (2023) Reduction of Portosystemic Gradient during Transjugular Intrahepatic Portosystemic Shunt Achieves Good Outcome and Reduces Complications. World Journal of Gastroenterology, 29, 2336-2348. https://doi.org/10.3748/wjg.v29.i15.2336
|
[24]
|
Li, J., Feng, D., Pang, N., et al. (2022) Controlling Nutritional Status Score as a New Indicator of Overt Hepatic Encephalopathy in Cirrhotic Patients Following Transjugular Intrahepatic Portosystemic Shunt. Clinical Nutrition (Edinburgh, Scotland), 41, 560-566. https://doi.org/10.1016/j.clnu.2021.12.036
|
[25]
|
Fallahzadeh, M.A. and Rahimi, R.S. (2022) Hepatic Encephalopathy: Current and Emerging Treatment Modalities. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association, 20, S9-S19. https://doi.org/10.1016/j.cgh.2022.04.034
|
[26]
|
Wang, M.W., Ma, W.J., Wang, Y., et al. (2023) Comparison of the Effects of Probiotics, Rifaximin, and Lactulose in the Treatment of Minimal Hepatic Encephalopathy and Gut Microbiota. Frontiers in Microbiology, 14, Article ID: 1091167. https://doi.org/10.3389/fmicb.2023.1091167
|
[27]
|
Sharma, B.C., Sharma, P., Agrawal, A., et al. (2009) Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose versus Placebo. Gastroenterology, 137, 885-891.E1. https://doi.org/10.1053/j.gastro.2009.05.056
|
[28]
|
Han, X., Luo, Z., Wang, W., et al. (2021) Efficacy and Safety of Rifaximin versus Placebo or Other Active Drugs in Critical Ill Patients with Hepatic Encephalopathy. Frontiers in Pharmacology, 12, Article ID: 696065. https://doi.org/10.3389/fphar.2021.696065
|
[29]
|
Hudson, M. and Schuchmann, M. (2019) Long-Term Management of Hepatic Encephalopathy with Lactulose and/or Rifaximin: A Review of the Evidence. European Journal of Gastroenterology & Hepatology, 31, 434-450. https://doi.org/10.1097/MEG.0000000000001311
|
[30]
|
Rocco, A., Sgamato, C., Compare, D., et al. (2021) Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives. Frontiers in Cell and Developmental Biology, 9, Article ID: 748253. https://doi.org/10.3389/fcell.2021.748253
|
[31]
|
Balzano, T., Llansola, M., Arenas, Y.M., et al. (2023) Hepatic Encephalopathy: Investigational Drugs in Preclinical and Early Phase Development. Expert Opinion on Investigational Drugs, 32, 1055-1069. https://doi.org/10.1080/13543784.2023.2277386
|
[32]
|
Bureau, C., Garcia Pagan, J.C., Layrargues, G.P., et al. (2007) Patency of Stents Covered with Polytetrafluoroethylene in Patients Treated by Transjugular Intrahepatic Portosystemic Shunts: Long-Term Results of a Randomized Multicentre Study. Liver International: Official Journal of the International Association for the Study of the Liver, 27, 742-747. https://doi.org/10.1111/j.1478-3231.2007.01522.x
|
[33]
|
Cura, M., Cura, A., Suri, R., et al. (2008) Causes of TIPS Dysfunction. AJR American Journal of Roentgenology, 191, 1751-1757. https://doi.org/10.2214/AJR.07.3534
|
[34]
|
Chen, S.L., Hu, P., Lin, Z.P., et al. (2019) The Effect of Puncture Sites of Portal Vein in TIPS with EPTFE-Covered Stents on Postoperative Long-Term Clinical Efficacy. Gastroenterology Research and Practice, 2019, Article ID: 2935498. https://doi.org/10.1155/2019/2935498
|
[35]
|
Luo, S.H., Chu, J.G., Huang, H., et al. (2017) Effect of Initial Stent Position on Patency of Transjugular Intrahepatic Portosystemic Shunt. World Journal of Gastroenterology, 23, 4779-4787. https://doi.org/10.3748/wjg.v23.i26.4779
|
[36]
|
Buechter, M., Manka, P., Theysohn, J.M., et al. (2018) Spleen Stiffness Is Positively Correlated with HVPG and Decreases Significantly after TIPS Implantation. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 50, 54-60. https://doi.org/10.1016/j.dld.2017.09.138
|
[37]
|
Manatsathit, W., Samant, H., Panjawatanan, P., et al. (2019) Performance of Ultrasound for Detection of Transjugular Intrahepatic Portosystemic Shunt Dysfunction: A Meta-Analysis. Abdominal Radiology (New York), 44, 2392-2402. https://doi.org/10.1007/s00261-019-01981-w
|
[38]
|
Li, Z., Jiao, D.C., Si, G., et al. (2020) Use of Fenestration to Revise Shunt Dysfunction after Transjugular Intrahepatic Portosystemic Shunt. Abdominal Radiology (New York), 45, 556-562. https://doi.org/10.1007/s00261-019-02329-0
|
[39]
|
Nardone, R., Höller, Y., Storti, M., et al. (2014) Spinal Cord Involvement in Patients with Cirrhosis. World Journal of Gastroenterology, 20, 2578-2585. https://doi.org/10.3748/wjg.v20.i10.2578
|
[40]
|
马富权, 黄金, 李伟之, 等. 减少门腔分流量对肝硬化患者经颈静脉肝内门体分流术后肝性脊髓病的影响[J]. 中华肝脏病杂志, 2022, 30(10): 1063-1068.
|
[41]
|
Lewis, M. and Howdle, P.D. (2003) The Neurology of Liver Failure. QJM: Monthly Journal of the Association of Physicians, 96, 623-633. https://doi.org/10.1093/qjmed/hcg110
|
[42]
|
Weissenborn, K., Tietge, U.J., Bokemeyer, M., et al. (2003) Liver Transplantation Improves Hepatic Myelopathy: Evidence by Three Cases. Gastroenterology, 124, 346-351. https://doi.org/10.1053/gast.2003.50062
|
[43]
|
Nardone, R., Orioli, A., Höller, Y., et al. (2014) Central Motor and Sensory Conduction in Patients with Hepatic Myelopathy. Spinal Cord, 52, 439-443. https://doi.org/10.1038/sc.2014.61
|
[44]
|
Wang, L.X., Guo, L., Guo, F., et al. (2017) Brain White Matter Fiber Tracts Involved in Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic Myelopathy. Neuroreport, 28, 1164-1169. https://doi.org/10.1097/WNR.0000000000000898
|
[45]
|
Liu, K., Chen, G., Ren, S.Y., et al. (2019) Regional Gray Matter Abnormality in Hepatic Myelopathy Patients after Transjugular Intrahepatic Portosystemic Shunt: A Voxel-Based Morphometry Study. Neural Regeneration Research, 14, 850-857. https://doi.org/10.4103/1673-5374.249233
|
[46]
|
Counsell, C. and Warlow, C. (1996) Failure of Presumed Hepatic Myelopathy to Improve after Liver Transplantation. Journal of Neurology, Neurosurgery, and Psychiatry, 60, 590. https://doi.org/10.1136/jnnp.60.5.590
|
[47]
|
López-Méndez, E., Zamora-Valdés, D., Díaz-Zamudio, M., et al. (2010) Liver Failure after an Uncovered TIPS Procedure Associated with Hepatic Infarction. World Journal of Hepatology, 2, 167-170. https://doi.org/10.4254/wjh.v2.i4.167
|
[48]
|
Gaba, R.C. and Lakhoo, J. (2016) What Constitutes Liver Failure after Transjugular Intrahepatic Portosystemic Shunt Creation? A Proposed Definition and Grading System. Annals of Hepatology, 15, 230-235.
|
[49]
|
Rajesh, S., George, T., Philips, C.A., et al. (2020) Transjugular Intrahepatic Portosystemic Shunt in Cirrhosis: An Exhaustive Critical Update. World Journal of Gastroenterology, 26, 5561-5596. https://doi.org/10.3748/wjg.v26.i37.5561
|
[50]
|
Yao, Y., Satapathy, S.K., Fernandes, E.S.M., et al. (2022) Hepatic Venous Pressure Gradient (HVPG) Predicts Liver Failure after Transjugular Intrahepatic Portal Shunt: A Retrospective Cohort Study. Annals of Translational Medicine, 10, 1122. https://doi.org/10.21037/atm-22-4737
|
[51]
|
Mukund, A., Aravind, A., Jindal, A., et al. (2024) Predictors and Outcomes of Post-Transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis. Digestive Diseases and Sciences, 69, 1025-1034. https://doi.org/10.1007/s10620-023-08256-x
|
[52]
|
Billey, C., Billet, S., Robic, M.A., et al. (2019) A Prospective Study Identifying Predictive Factors of Cardiac Decompensation after Transjugular Intrahepatic Portosystemic Shunt: The Toulouse Algorithm. Hepatology (Baltimore, Md), 70, 1928-1941. https://doi.org/10.1002/hep.30934
|
[53]
|
Modha, K., Kapoor, B., Lopez, R., et al. (2018) Symptomatic Heart Failure after Transjugular Intrahepatic Portosystemic Shunt Placement: Incidence, Outcomes, and Predictors. Cardiovascular and Interventional Radiology, 41, 564-571. https://doi.org/10.1007/s00270-017-1848-1
|
[54]
|
Ali, A., Sarwar, A., Patwardhan, V.R., et al. (2022) Echocardiographic and Other Preprocedural Predictors of Heart Failure after TIPS Placement in Patients with Cirrhosis: A Single-Center 15-Year Analysis. AJR American Journal of Roentgenology, 219, 110-118. https://doi.org/10.2214/AJR.21.26947
|